A model for the Dutch pharmaceutical market

Erik Canton and Ed Westerhout

Health Economics, 1999, vol. 8, issue 5, 391-402

Abstract: This paper develops a general‐equilibrium model for the Dutch pharmaceutical market. The model derives the behaviour of patients, pharmacists, drug producers and parallel‐importers from microeconomic principles and recognizes the interactions between the various actors. The latter is important since the general‐equilibrium effects are sometimes at odds with intuition from a partial‐equilibrium approach. A calibrated version of the model is used to evaluate the effects of various policy experiments on the bill for pharmaceutical care in the Netherlands. These experiments include an incentive policy to encourage cost‐conscious drug distribution, an increase of copayments for pharmaceutical care, a reduction of trade barriers for parallel‐importers, and market entry by producers of generic substitutes. Copyright © 1999 John Wiley & Sons, Ltd.

Date: 1999
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
https://doi.org/10.1002/(SICI)1099-1050(199908)8:53.0.CO;2-7

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:8:y:1999:i:5:p:391-402

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().